Global Insomnia Treatment Market 2026 -
Players, Regions, Product Types, Application & Forecast Analysis
Global Insomnia Treatment Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis
Chapter 1 Insomnia Treatment Market Overview
1.1 Insomnia Treatment Definition
1.2 Global Insomnia Treatment Market Size Status and Outlook (2019-2032)
1.3 Global Insomnia Treatment Market Size Comparison by Region (2019-2032)
1.4 Global Insomnia Treatment Market Size Comparison by Type (2019-2032)
1.5 Global Insomnia Treatment Market Size Comparison by Application (2019-2032)
1.6 Global Insomnia Treatment Market Size Comparison by Sales Channel (2019-2032)
1.7 Insomnia Treatment Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)
1.7.4 COVID-19 Impacts
1.7.5 Russia-Ukraine War Impacts
1.7.6 US-Israel-Iran War Impacts
Chapter 2 Executive Summary
2.1 Global Insomnia Treatment Market Snapshot
2.2 Global Insomnia Treatment Market Volume & Revenue (2019-2025)
2.3 Global Insomnia Treatment Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)
2.4 Global Insomnia Treatment Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)
2.5 Global Insomnia Treatment Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)
2.6 Global Insomnia Treatment Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)
Chapter 3 Insomnia Treatment Market Segment Analysis by Player
3.1 Global Insomnia Treatment Sales and Market Share by Player (2023-2025)
3.2 Global Insomnia Treatment Revenue and Market Share by Player (2023-2025)
3.3 Global Insomnia Treatment Average Price by Player (2023-2025)
3.4 Players Competition Situation & Trends (2023-2025)
3.5 Conclusion of Segment by Player
Chapter 4 Insomnia Treatment Market Segment Analysis by Type
4.1 Global Insomnia Treatment Market by Type
4.1.1 Benzodiazepines
4.1.2 Nonbenzodiazepines
4.1.3 Antidepressants
4.1.4 Orexin Antagonists
4.1.5 Melatonin Antagonists
4.2 Global Insomnia Treatment Sales and Market Share by Type (2019-2025)
4.3 Global Insomnia Treatment Revenue and Market Share by Type (2019-2025)
4.4 Global Insomnia Treatment Average Price by Type (2019-2025)
4.5 Leading Players of Insomnia Treatment by Type in 2025
4.6 Conclusion of Segment by Type
Chapter 5 Insomnia Treatment Market Segment Analysis by Application
5.1 Global Insomnia Treatment Market by Application
5.1.1 Hospital Pharmacies
5.1.2 Retail Pharmacies
5.1.3 Online Pharmacies
5.2 Global Insomnia Treatment Revenue and Market Share by Application (2019-2025)
5.3 Leading Consumers of Insomnia Treatment by Application in 2025
5.4 Conclusion of Segment by Application
Chapter 6 Insomnia Treatment Market Segment Analysis by Sales Channel
6.1 Global Insomnia Treatment Market by Sales Channel
6.1.1 Global Insomnia Treatment Market, by Direct Channel Market Analysis (2019-2032) (USD Million)
6.1.2 Global Insomnia Treatment Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)
6.2 Global Insomnia Treatment Revenue and Market Share by Sales Channel (2019-2025)
6.3 Leading Distributors/Dealers of Insomnia Treatment by Sales Channel in 2025
6.4 Conclusion of Segment by Sales Channel
Chapter 7 Insomnia Treatment Market Segment Analysis by Region
7.1 Global Insomnia Treatment Market Size and CAGR by Region (2019-2032)
7.2 Global Insomnia Treatment Sales and Market Share by Region (2019-2025)
7.3 Global Insomnia Treatment Revenue and Market Share by Region (2019-2025)
7.4 North America
7.4.1 North America Market by Country
7.4.2 North America Insomnia Treatment Market Share by Type
7.4.3 North America Insomnia Treatment Market Share by Application
7.4.4 United States
7.4.5 Canada
7.4.6 Mexico
7.5 Europe
7.5.1 Europe Market by Country
7.5.2 Europe Insomnia Treatment Market Share by Type
7.5.3 Europe Insomnia Treatment Market Share by Application
7.5.4 Germany
7.5.5 United Kingdom
7.5.6 France
7.5.7 Italy
7.5.8 Russia
7.5.9 Spain
7.5.10 Benelux
7.5.11 Poland
7.5.12 Austria
7.5.13 Portugal
7.5.14 Rest of Europe
7.6 Asia-Pacific
7.6.1 Asia-Pacific Market by Country
7.6.2 Asia-Pacific Insomnia Treatment Market Share by Type
7.6.3 Asia-Pacific Insomnia Treatment Market Share by Application
7.6.4 China
7.6.5 Japan
7.6.6 Korea
7.6.7 India
7.6.8 Southeast Asia
7.6.9 Australia
7.6.10 Taiwan
7.6.11 Rest of Asia Pacific
7.7 South America
7.7.1 South America Market by Country
7.7.2 South America Insomnia Treatment Market Share by Type
7.7.3 South America Insomnia Treatment Market Share by Application
7.7.4 Brazil
7.7.5 Argentina
7.7.6 Colombia
7.7.7 Chile
7.7.8 Peru
7.7.9 Venezuela
7.7.10 Rest of South America
7.8 Middle East & Africa
7.8.1 Middle East & Africa Market by Country
7.8.2 Middle East & Africa Insomnia Treatment Market Share by Type
7.8.3 Middle East & Africa Insomnia Treatment Market Share by Application
7.8.4 UAE
7.8.5 Saudi Arabia
7.8.6 South Africa
7.8.7 Egypt
7.8.8 Nigeria
7.9.9 Rest of Middle East & Africa
7.9 Conclusion of Segment by Region
Chapter 8 Profile of Leading Insomnia Treatment Players
8.1 Meda Consumer Healthcare
8.1.1 Company Snapshot
8.1.2 Product/Service Offered
8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.1.4 Recent Developments
8.2 Takeda Pharmaceuticals
8.2.1 Company Snapshot
8.2.2 Product/Service Offered
8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.2.4 Recent Developments
8.3 Pfizer
8.3.1 Company Snapshot
8.3.2 Product/Service Offered
8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.3.4 Recent Developments
8.4 Sanofi
8.4.1 Company Snapshot
8.4.2 Product/Service Offered
8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.4.4 Recent Developments
8.5 Vanda Pharmaceuticals
8.5.1 Company Snapshot
8.5.2 Product/Service Offered
8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.5.4 Recent Developments
8.6 Pernix Therapeutics
8.6.1 Company Snapshot
8.6.2 Product/Service Offered
8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.6.4 Recent Developments
8.7 Purdue Pharmaceuticals
8.7.1 Company Snapshot
8.7.2 Product/Service Offered
8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.7.4 Recent Developments
8.8 Mylan
8.8.1 Company Snapshot
8.8.2 Product/Service Offered
8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.8.4 Recent Developments
8.9 Teva Pharmaceutical
8.9.1 Company Snapshot
8.9.2 Product/Service Offered
8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.9.4 Recent Developments
8.10 Sumitomo Dainippon Pharma
8.10.1 Company Snapshot
8.10.2 Product/Service Offered
8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.10.4 Recent Developments
8.11 Paratek Pharmaceuticals
8.11.1 Company Snapshot
8.11.2 Product/Service Offered
8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.11.4 Recent Developments
8.12 Ebb Therapeutics
8.12.1 Company Snapshot
8.12.2 Product/Service Offered
8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.12.4 Recent Developments
8.13 Astellas
8.13.1 Company Snapshot
8.13.2 Product/Service Offered
8.13.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.13.4 Recent Developments
8.14 Dainippon Sumitomo
8.14.1 Company Snapshot
8.14.2 Product/Service Offered
8.14.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.14.4 Recent Developments
8.15 Flynn Pharma
8.15.1 Company Snapshot
8.15.2 Product/Service Offered
8.15.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.15.4 Recent Developments
8.16 Johnson & Johnson
8.16.1 Company Snapshot
8.16.2 Product/Service Offered
8.16.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.16.4 Recent Developments
8.17 Somnus Therapeutics
8.17.1 Company Snapshot
8.17.2 Product/Service Offered
8.17.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.17.4 Recent Developments
8.18 Neurim
8.18.1 Company Snapshot
8.18.2 Product/Service Offered
8.18.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.18.4 Recent Developments
8.19 Minerva Neurosciences
8.19.1 Company Snapshot
8.19.2 Product/Service Offered
8.19.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.19.4 Recent Developments
8.20 SkyePharma
8.20.1 Company Snapshot
8.20.2 Product/Service Offered
8.20.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.20.4 Recent Developments
Chapter 9 Upstream and Downstream Analysis of Insomnia Treatment
9.1 Industrial Chain of Insomnia Treatment
9.2 Upstream of Insomnia Treatment
9.2.1 Raw Materials (If Applicable)
9.2.2 Manufacturing Cost Structure (If Applicable)
9.2.3 Manufacturing Process (If Applicable)
9.3 Downstream of Insomnia Treatment
9.3.1 Leading Distributors/Dealers of Insomnia Treatment
9.3.2 Leading Consumers of Insomnia Treatment
Chapter 10. Global Insomnia Treatment Market Industry Analysis
10.1. Porter's Five Forces Analysis
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Buyers/Consumers
10.1.3. Bargaining Power of Suppliers
10.1.4. Threat of Substitute Types
10.1.5. Intensity of Competitive Rivalry
10.2. Major Growth Avenues within Global Insomnia Treatment Market
10.2.1. Product Types
10.2.2. Applications
10.2.3. Sales Channels
10.2.4. Country
10.3. Insomnia Treatment Industry Ecosystem
10.4. Price Trend Analysis (If Applicable)
10.5. Buying Criteria (If Applicable)
10.6. Regulations (If Applicable)
Chapter 11 Development Trend of Insomnia Treatment (2026-2032)
11.1 Global Insomnia Treatment Market Size (Sales and Revenue) Forecast (2026-2032)
11.2 Global Insomnia Treatment Market Size and CAGR Forecast by Region (2026-2032)
11.3 Global Insomnia Treatment Market Size and CAGR Forecast by Type (2026-2032)
11.4 Global Insomnia Treatment Market Size and CAGR Forecast by Application (2026-2032)
11.5 Global Insomnia Treatment Market Size and CAGR Forecast by Sales Channel (2026-2032)
Chapter 12. Import - Export Analysis (If Applicable)
12.1 North America Insomnia Treatment Import-Export (2019-2025)
12.2 Europe Insomnia Treatment Import-Export (2019-2025)
12.3 Asia Pacific Insomnia Treatment Import-Export (2019-2025)
12.4 South America Insomnia Treatment Import-Export (2019-2025)
12.5 Middle East & Africa Insomnia Treatment Import-Export (2019-2025)
Chapter 13. Demand-Supply Gap Analysis
13.1 North America Insomnia Treatment Demand-Supply (2019-2025)
13.2 Europe Insomnia Treatment Demand-Supply (2019-2025)
13.3 Asia Pacific Insomnia Treatment Demand-Supply (2019-2025)
13.4 South America Insomnia Treatment Demand-Supply (2019-2025)
13.5 Middle East & Africa Insomnia Treatment Demand-Supply (2019-2025)
Chapter 14 Appendix
14.1 Research Methodology
14.2 Data Sources
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.